Last reviewed · How we verify
NCT06179797
Chronic Remote Ischemic Conditioning in Vascular Cognitive Impairment: A Dose Escalation Study
NA trial testing remote ischemic conditioning in Age-related Cerebral White Matter Changes in 40 participants. Status unknown.
15 December 2023
Quick facts
| Lead sponsor | Augusta University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 15 August 2020 |
| Primary completion | 15 December 2023 |
| Estimated completion | 15 December 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- remote ischemic conditioning
Conditions studied
- Age-related Cerebral White Matter Changes — all drugs for Age-related Cerebral White Matter Changes →
- Cognition Disorder — all drugs for Cognition Disorder →
Sponsor
Augusta University
Who can join
56 and older, any sex, with Age-related Cerebral White Matter Changes or Cognition Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the dose-response of relevant blood biomarkers to remote ischemic conditioning in patients with age-related cerebral white matter hyperintensities on MRI, in preparation for a subsequent larger efficacy trial.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Potential of Chronic Remote Ischemic Conditioning in Cerebral Small Vessel Disease.
Hess DC, Bruno A, Khan MB, Kamat P, et al · · 2024 · PMID 40130169
Verify or expand the search:
- PubMed search for NCT06179797
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of remote ischemic conditioning
Trials testing the same drug.
- NCT07270887 — The Long-term Effect of Remote Ischemic Conditioning on Main Organs in ASVCD Patients With Very High Risks · recruiting
- NCT06931535 — Remote Ischemic Conditioning for Acute Moderate Posterior Ischemic Stroke · NA · recruiting
- NCT06826144 — Chronic Remote Ischemic Conditioning in Small Infarctions Associated with Stent-assisted Coiling of Unruptured Intracran · NA · not yet recruiting
- NCT05599009 — Remote Ischemic Conditioning and Dynamic Cerebral Autoregulation in Patients With Intracranial and Extracranial Arterios · NA · unknown
- NCT05263531 — Remote Ischemic Conditioning for Motor Recovery After Acute Ischemic Stroke · NA · unknown
Other Augusta University trials
Trials by the same sponsor.
- NCT07341841 — Assessing Obesity Related Risk Factors in Adult Population: A Genetic and Behavioral Study · NA · enrolling by invitation
- NCT07489144 — CO-creating Novel, Feasible, and Inclusive Research Methods · NA · active not recruiting
- NCT06514014 — Transition From Donor Milk: a Feasibility Study · NA · recruiting
- NCT06907992 — A Study Comparing Short-course Antifungal Therapy (SCAT) 7 Day vs Standard 14 Day Antifungal Therapy for Uncomplicated C · not yet recruiting
- NCT06058169 — Effects of Home Base Whole-body Vibration in Osteoarthritis. (VIBE-Rx2) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06179797 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Augusta University
- Last refreshed: 22 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06179797.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing